Growth Metrics

Penumbra (PEN) EBIT Growth (1y) (2015 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -20.56%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 11.83%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -11.06%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 19.54%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 20.97%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 74.18%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 90.95%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -18.12%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 46.60%
10 Penumbra 12.52 Bn 11.91 Bn 253.41 Mn -5.24%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -5.24%
Dec 31, 2025 38.48%
Sep 30, 2025 38.10%
Jun 30, 2025 150.43%
Mar 31, 2025 233.44%
Dec 31, 2024 22.11%
Sep 30, 2024 180.11%
Jun 30, 2024 -552.57%
Mar 31, 2024 51.11%
Dec 31, 2023 624.79%
Sep 30, 2023 132.33%
Jun 30, 2023 12,969.78%
Mar 31, 2023 297.92%
Dec 31, 2022 112.07%
Sep 30, 2022 -38.12%
Jun 30, 2022 -101.35%
Mar 31, 2022 -130.05%
Dec 31, 2021 -2,195.53%
Sep 30, 2021 143.56%
Jun 30, 2021 158.43%
Mar 31, 2021 2,107.05%
Dec 31, 2020 -116.49%
Sep 30, 2020 -255.35%
Jun 30, 2020 -237.87%
Mar 31, 2020 -94.53%
Dec 31, 2019 58.63%
Sep 30, 2019 162.24%
Jun 30, 2019 37.90%
Mar 31, 2019 175.70%
Dec 31, 2018 72.95%
Sep 30, 2018 -3,152.56%
Jun 30, 2018 799.02%
Mar 31, 2018 297.70%
Dec 31, 2017 434.72%
Sep 30, 2017 150.11%
Jun 30, 2017 -98.21%
Mar 31, 2017 -211.50%
Dec 31, 2016 -163.30%
Sep 30, 2016 -162.47%
Jun 30, 2016 82.43%
Mar 31, 2016 -54.01%
Dec 31, 2015 465.22%
Sep 30, 2015 601.61%
Jun 30, 2015 -118.42%
Mar 31, 2015 -77.14%